Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it.

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

Thousands of premature babies in the UK can now be protected against a common winter virus which can cause a dangerous lung ...

New research has suggested that vaccination of pregnant women has been linked to a drop in newborns being admitted to ...

With Canada’s colder weather comes respiratory virus season, as flus and respiratory syncytial virus (RSV) circulate alongside COVID-19.While Canadians learned a lot about how to protect ...

RSV can lead to a severe lung infection called bronchiolitis, which is dangerous in babies and can result in them being ...

Respiratory syncytial virus is common, is quite contagious and infects most kids before their second birthday — that is, it did before the COVID-19 pandemic happened.

RSV (respiratory syncytial virus) is a virus that infects the lungs and breathing passages. It is one of the major remaining infectious diseases for which there is currently no vaccine or specific ...

A vaccine in the Respiratory Syncytial Virus Infection pipeline presents a cost-effective solution to reducing the burden of RSV, as current options for both prevention and treatment are limited ...